{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:13:37Z","timestamp":1778282017939,"version":"3.51.4"},"reference-count":124,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["heartfailure.theclinics.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.hfc.2017.02.007","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T20:15:21Z","timestamp":1494101721000},"page":"513-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Heart Failure Complicating Acute Myocardial Infarction"],"prefix":"10.1016","volume":"13","author":[{"given":"Wilbert S.","family":"Aronow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2017.02.007_bib1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.crd.0000175289.87583.e5","article-title":"Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients","volume":"14","author":"Aronow","year":"2006","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.hfc.2017.02.007_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1378\/chest.113.4.867","article-title":"Normal left ventricular ejection fraction in older persons with congestive heart failure","volume":"113","author":"Aronow","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2017.02.007_bib3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1378\/chest.115.3.867","article-title":"Incidence of heart failure in 2,737 older persons with and without diabetes mellitus","volume":"115","author":"Aronow","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2017.02.007_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0002-9149(99)00392-6","article-title":"Comparison of incidences of congestive heart failure in older African-Americans, Hispanics, and whites","volume":"84","author":"Aronow","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9343(92)90008-Y","article-title":"Is age an independent predictor of early and late mortality in patients with acute myocardial infarction?","volume":"92","author":"Rich","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib6","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/01.CIR.92.5.1133","article-title":"Influence of sex on the short-term outcome of elderly patients with a first acute myocardial infarction","volume":"92","author":"Bueno","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib7","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0002-9149(96)00129-4","article-title":"Influence of gender on short- and long-term mortality after acute myocardial infarction","volume":"77","author":"Kober","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jama.1996.03530340041027","article-title":"Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy","volume":"275","author":"Weaver","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2017.02.007_bib9","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/0002-9149(87)90418-8","article-title":"Prevalence of presenting symptoms of recognized acute myocardial infarction and of unrecognized healed myocardial infarction in elderly patients","volume":"60","author":"Aronow","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.CIR.45.5.1125","article-title":"Heart failure complicating acute myocardial infarction","volume":"45","author":"Wolk","year":"1972","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0002-9149(89)90001-5","article-title":"Clinical characteristics and natural history of survivors of pulmonary congestion during acute myocardial infarction","volume":"63","author":"Dwyer","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0002-9149(92)90850-X","article-title":"Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction","volume":"69","author":"Gottlieb","year":"1992","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2017.02.007_bib13","article-title":"Heart failure complicating acute myocardial infarction; burden and timing of occurrence: a nation-wide analysis including 86,771 patients from the Cardiovascular Disease in Norway (CVDNOR) Project","volume":"5","author":"Sulo","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hfc.2017.02.007_bib14","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM197612092952406","article-title":"Medical therapy of acute myocardial infarction by the application of hemodynamic subsets","volume":"295","author":"Forrester","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib15","first-page":"1115","article-title":"GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib16","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0002-9149(90)91112-J","article-title":"Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease","volume":"66","author":"Aronow","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib17","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0002-9149(00)00777-3","article-title":"Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction","volume":"85","author":"Aronow","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib18","first-page":"1597","article-title":"Treatment of systolic and diastolic heart failure in elderly persons","volume":"60A","author":"Aronow","year":"2006","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.hfc.2017.02.007_bib19","series-title":"Tresch and Aronow's cardiovascular disease in the elderly","first-page":"238","article-title":"Therapy of acute myocardial infarction","author":"Rich","year":"2013"},{"key":"10.1016\/j.hfc.2017.02.007_bib20","first-page":"81","article-title":"Echo in the elderly","volume":"8","author":"Aronow","year":"1990","journal-title":"Cardio"},{"key":"10.1016\/j.hfc.2017.02.007_bib21","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0002-9149(89)90750-9","article-title":"Usefulness of color Doppler flow imaging to distinguish ventricular septal defect from acute mitral regurgitation complicating acute myocardial infarction","volume":"64","author":"Harrison","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib22","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/0002-8703(82)90408-2","article-title":"Remote right ventricular infarction mimicking pericardial constriction","volume":"103","author":"Butman","year":"1982","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2017.02.007_bib23","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0735-1097(10)80038-5","article-title":"Doppler color flow mapping in the diagnosis of ventricular septal rupture and acute mitral regurgitation after myocardial infarction","volume":"15","author":"Smyllie","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jacc.2004.07.002","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction\u2014executive summary","volume":"44","author":"Antman","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.CIR.52.3.360","article-title":"Reduction of infarct size by oxygen inhalation following acute coronary occlusion","volume":"52","author":"Maroko","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/0002-8703(70)90281-4","article-title":"Arterial oxygen tension in acute myocardial infarction: serial analysis of clinical state and blood gas changes","volume":"79","author":"Fillmore","year":"1970","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2017.02.007_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1152\/jappl.1981.51.2.499","article-title":"Respiratory muscle fatigue during cardiogenic shock","volume":"51","author":"Aubier","year":"1981","journal-title":"J\u00a0Appl Physiol Respir Environ Exerc Physiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib28","series-title":"Principles and practice of medical intensive care","first-page":"924","article-title":"Mechanical ventilation and weaning","author":"Hyzy","year":"1993"},{"key":"10.1016\/j.hfc.2017.02.007_bib29","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1172\/JCI107869","article-title":"The cardiovascular effects of morphine: the peripheral capacitance and resistance vessels in human subjects","volume":"54","author":"Zelis","year":"1974","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.hfc.2017.02.007_bib30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.CIR.54.2.335","article-title":"The effects of morphine on venous tone in patients with acute pulmonary edema","volume":"54","author":"Vismara","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib31","first-page":"53","article-title":"Updated treatment for left ventricular failure and acute cardiogenic pulmonary edema","volume":"2","author":"Butman","year":"1981","journal-title":"ER Rep"},{"key":"10.1016\/j.hfc.2017.02.007_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0002-9149(79)90049-3","article-title":"Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction","volume":"43","author":"Biddle","year":"1973","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib33","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJM197305242882102","article-title":"Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction","volume":"288","author":"Dikshit","year":"1973","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib34","doi-asserted-by":"crossref","first-page":"73B","DOI":"10.1016\/0002-9149(92)90597-R","article-title":"Role of nitrates in acute myocardial infarction","volume":"70","author":"Flaherty","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib35","doi-asserted-by":"crossref","first-page":"82B","DOI":"10.1016\/0002-9149(92)90598-S","article-title":"Role of nitrates after acute myocardial infarction","volume":"70","author":"Jugdutt","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib36","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.54.4.624","article-title":"Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction","volume":"54","author":"Come","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib38","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJM199404283301707","article-title":"Right ventricular infarction","volume":"330","author":"Kinch","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib39","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0002-9149(82)90196-5","article-title":"Task force IV: pharmacologic interventions. Emergency cardiac care","volume":"50","author":"Gunnar","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O'Connor","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1056\/NEJM199209033271002","article-title":"Effects of the early administration of enalapril on mortality in patients with myocardial infarction","volume":"327","author":"Swedberg","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1056\/NEJM199108013250502","article-title":"A\u00a0comparison of enalapril with hydralazine-isosorbide dinitrate in\u00a0the treatment of chronic congestive heart failure","volume":"325","author":"Cohn","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib43","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1056\/NEJM199501123320203","article-title":"The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction","volume":"332","author":"Ambrosioni","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib45","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A\u00a0clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"Kober","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib46","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(95)90866-8","article-title":"Oral captopril versus placebo among 13,364 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1)","volume":"345","author":"Lisheng","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0735-1097(95)00498-X","article-title":"Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six-weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico","volume":"27","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib48","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib49","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0002-9149(01)02092-6","volume":"88","author":"Aronow","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib50","first-page":"1328","article-title":"ACC\/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)","volume":"28","author":"Ryan","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl B","key":"10.1016\/j.hfc.2017.02.007_bib51","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/eurheartj\/15.suppl_B.14","article-title":"Left ventricular remodelling, neurohormonal activation and early treatment with enalapril (CONSENSUS II) following myocardial infarction","volume":"15","author":"Sigurdsson","year":"1994","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2017.02.007_bib52","first-page":"1429","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group","volume":"316","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib53","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators","volume":"325","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib54","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0002-9149(93)90520-M","article-title":"Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction","volume":"71","author":"Aronow","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9343(00)00601-X","article-title":"Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors","volume":"109","author":"Philbin","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib56","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib57","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial\u2014the Losartan Heart Failure Survival Study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib58","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A\u00a0randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib59","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib60","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib61","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib62","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib64","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib66","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(81)91101-6","article-title":"Effect on mortality of metoprolol in acute myocardial infarction","volume":"2","author":"Hjalmarson","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib67","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group","volume":"6","year":"1985","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2017.02.007_bib68","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16 027 cases of suspected acutemyocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group","volume":"2","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib69","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","article-title":"Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study","volume":"83","author":"Roberts","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib70","first-page":"60","article-title":"Drug treatment after acute myocardial infarction: is treatment the same for the elderly as in\u00a0the young patient?","volume":"7","author":"Smith","year":"1998","journal-title":"Am J Geriatr Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib71","doi-asserted-by":"crossref","first-page":"40J","DOI":"10.1016\/S0002-9149(97)00838-2","article-title":"Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the G\u00f6teborg Metoprolol Trial)","volume":"80","author":"Herlitz","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib72","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.1993.03510130095038","article-title":"Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials","volume":"270","author":"Teo","year":"1993","journal-title":"JAMA"},{"issue":"Suppl I","key":"10.1016\/j.hfc.2017.02.007_bib73","first-page":"I57","article-title":"Beta blockade after myocardial infarction: the Norwegian Propranolol Study in high-risk patients","volume":"67","author":"Hansteen","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib74","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.CIR.66.6.1179","article-title":"Timolol-related reduction in mortality and reinfarction in patients ages 65\u201375 years surviving acute myocardial infarction","volume":"66","author":"Gundersen","year":"1982","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib75","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM198510243131705","article-title":"Six-year follow-up of the Norwegian Multicentre Study on Timolol after acute myocardial infarction","volume":"313","author":"Pedersen","year":"1985","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib76","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A\u00a0randomized trial of propranolol in patients with acute myocardial infarction","volume":"247","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2017.02.007_bib77","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1532-5415.1995.tb07044.x","article-title":"Utility of betablockade treatment for older postinfarction patients","volume":"43","author":"Park","year":"1995","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.hfc.2017.02.007_bib78","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.CIR.73.3.503","article-title":"Effect of propranolol after acute myocardial infarction in patients with congestive heart failure","volume":"73","author":"Chadda","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib79","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ehj\/9.1.8","article-title":"The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group","volume":"9","year":"1988","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2017.02.007_bib80","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","author":"CIBIS-II Investigators and Committees","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib82","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2017.02.007_bib83","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib84","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2009.02.046","article-title":"Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure)","volume":"53","author":"van Veldhuisen","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib85","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0002-9149(97)00320-2","volume":"80","author":"Aronow","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib86","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/jama.1997.03540260029031","article-title":"Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction","volume":"277","author":"Soumerai","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2017.02.007_bib87","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MJT.0b013e3181f2abb3","article-title":"Effect of carvedilol versus metoprolol CR\/XL on mortality in patients with heart failure treated with cardiac resynchronization therapy: a Cox multivariate regression analysis","volume":"20","author":"Shen","year":"2013","journal-title":"Am J Ther"},{"key":"10.1016\/j.hfc.2017.02.007_bib88","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0002-9149(90)90592-O","article-title":"Evaluating effects of treatment subgroups of patients within a clinical trial: the case of non-Q-wave myocardial infarction and beta blockers","volume":"60","author":"Yusuf","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib89","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198808183190701","article-title":"The effect of diltiazem on mortality and reinfarction after myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group","volume":"319","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib90","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/01.CIR.83.1.52","article-title":"Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction","volume":"83","author":"Goldstein","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib91","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine: dose-related increase in mortality in patients with coronary heart disease","volume":"92","author":"Furberg","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib92","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/0002-9149(91)90944-G","article-title":"Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies","volume":"67","author":"Yusuf","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib93","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.82.6.1954","article-title":"A\u00a0prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure","volume":"82","author":"Elkayam","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib94","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2165\/00002512-199101020-00002","article-title":"Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment?","volume":"1","author":"Aronow","year":"1991","journal-title":"Drugs Aging"},{"key":"10.1016\/j.hfc.2017.02.007_bib95","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib96","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0735-1097(01)01442-5","article-title":"Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG Study","volume":"38","author":"Rich","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib97","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ejheart.2005.10.002","article-title":"Serum digoxin concentration and outcomes in women with heart failure: a bi-directional effect and a possible effect modification by ejection fraction","volume":"8","author":"Ahmed","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2017.02.007_bib98","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1532-5415.1995.tb07337.x","article-title":"A\u00a0randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure","volume":"43","author":"Rich","year":"1995","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"Suppl II","key":"10.1016\/j.hfc.2017.02.007_bib99","article-title":"Intermittent dobutamine in ambulatory out-patients with chronic cardiac failure","volume":"74","author":"Dies","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-8703(99)70250-4","article-title":"Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)","volume":"138","author":"O\u2019Connor","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2017.02.007_bib101","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/0002-9149(94)90308-5","article-title":"Betablocker therapy in the Cardiac Arrhythmia Suppression Trial","volume":"74","author":"Kennedy","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib102","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9149(94)90369-7","article-title":"Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients R62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction R40%","volume":"74","author":"Aronow","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib103","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jacc.2012.07.009","volume":"60","author":"Tracy","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib104","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.amjcard.2014.05.045","article-title":"Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults","volume":"114","author":"Bajaj","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib105","first-page":"3","article-title":"Management of atrial fibrillation in the elderly","volume":"100","author":"Aronow","year":"2009","journal-title":"Minerva Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib106","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib107","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib108","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib109","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0003-4975(10)60426-2","article-title":"Diagnosis of treatment of subacute free wall ventricular rupture after infarction","volume":"35","author":"Nunez","year":"1983","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.hfc.2017.02.007_bib111","first-page":"948","article-title":"Mechanical complications of acute myocardial infarction","volume":"5","author":"Labovitz","year":"1984","journal-title":"Cardiovasc Rev Rep"},{"key":"10.1016\/j.hfc.2017.02.007_bib112","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.1990.03440090071029","article-title":"Surgical treatment of complications of acute myocardial infarction","volume":"263","author":"Bolooki","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2017.02.007_bib113","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9149(92)91266-7","article-title":"Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention","volume":"70","author":"Lemery","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib114","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742c84","volume":"127","author":"O'Gara","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2017.02.007_bib115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or\u00a0an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib116","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib117","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.hfc.2017.02.007_bib118","first-page":"24","article-title":"CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction","volume":"60","author":"Aronow","year":"2005","journal-title":"Geriatrics"},{"key":"10.1016\/j.hfc.2017.02.007_bib119","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib120","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac- resynchronization therapy for the prevention of heart- failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib121","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hfc.2017.02.007_bib122","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2017.02.007_bib123","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehr162","article-title":"Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial","volume":"32","author":"Brignole","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2017.02.007_bib124","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.amjcard.2009.01.023","article-title":"Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices","volume":"103","author":"Vatankulu","year":"2009","journal-title":"Am J Cardiol"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155171361730020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155171361730020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T08:51:34Z","timestamp":1658998294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155171361730020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":124,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S155171361730020X"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2017.02.007","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart Failure Complicating Acute Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2017.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}